OBJECTIVE - To investigate the impact of glycemic control on the survival o
f diabetic subjects with end-stage renal disease (ESRD) starting hemodialys
is treatment.
RESEARCH DESIGN AND METHODS - This single-center prospective observational
study enrolled 150 diabetic ESRD subjects (109 men and 41 women; age at hem
odialysis initiation, 60.5 +/- 10.2 years) at start of hemodialysis between
January 1989 and December 1997. The subjects were divided into groups acco
rding to their glycemic control level at inclusion as follows: good HbA(1c)
<7.5%, n = 93 (group G), and poor HbA(1c) <greater than or equal to>7.5%,
n = 57 (group P); and survival was followed until December 1999, with a mea
n follow-up period of 2.7 years.
RESULTS - Group G had better survival than group P (the control group) (P =
0.008). At inclusion, there was no significant difference in age, sex, sys
tolic blood pressure (SBP), BMI, cardio-to-thoracic ratio (CTR) on chest X-
ray, and serum creatinine (Cre) or hemoglobin (Hb) levels between the two g
roups. After adjustment for age and sex, HbA(1c) was a significant predicto
r of survival (hazard ratio 1.133 per 1.0% increment of HbA1c, 95% CI 1.028
-1.249, P = 0.012), as were Cre and CTR.
CONCLUSIONS - Good glycemic control (HbA(1c) <7.5%) predicts better surviva
l of diabetic ESRD patients starting hemodialysis treatment.